ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MRK Merck and Co Inc

130.4071
2.84 (2.22%)
After Hours
Last Updated: 19:34:12
Delayed by 15 minutes

Period:

Draw Mode:

Volume 6,713,422
Bid Price
Ask Price
News -
Day High 130.425

Low
99.14

52 Week Range

High
133.10

Day Low 127.01
Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
2.84 2.22% 130.4071 19:34:12
Open Price Low Price High Price Close Price Prev Close
127.01 127.01 130.425 130.38 127.57
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
87,120 6,713,422 $ 128.23 $ 860,844,312 - 99.14 - 133.10
Last Trade Time Type Quantity Stock Price Currency
19:51:43 1 $ 130.00 USD

Merck (MRK) Options Flow Summary

Overall Flow

Bullish

Net Premium

686k

Calls / Puts

300.00%

Buys / Sells

220.00%

OTM / ITM

77.78%

Sweeps Ratio

0.00%

Merck and Co Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
330.21B 2.53B - 60.12B 365M 0.14 904.79
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Merck News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MRK Message Board. Create One! See More Posts on MRK Message Board See More Message Board Posts

Historical MRK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week131.05131.05126.76128.286,611,477-0.6429-0.49%
1 Month126.76132.80124.50127.557,021,1413.652.88%
3 Months125.95133.10119.23125.988,306,9964.463.54%
6 Months104.38133.1099.80117.938,410,82626.0324.93%
1 Year116.85133.1099.14113.487,724,63913.5611.60%
3 Years77.81133.1070.8994.029,891,74752.6067.60%
5 Years78.89133.1065.2588.589,952,48151.5265.30%

Merck Description

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Your Recent History

Delayed Upgrade Clock